Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by J. Martí.
Clinical Journal of The American Society of Nephrology | 2008
Roser Torra; Joaquim Sarquella; Jordi Calabia; J. Martí; Elisabet Ars; Patricia Fernández-Llama; José Ballarín
BACKGROUND AND OBJECTIVES Autosomal dominant polycystic kidney disease is a systemic disorder with a wide range of extrarenal involvement. The scope of this study was to analyze the prevalence of seminal cysts and to correlate these findings with the sperm parameters in patients with autosomal dominant polycystic kidney disease. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS A prospective study enrolled 30 adult men with autosomal dominant polycystic kidney disease. Of these 30 patients, 22 agreed to provide a semen sample for analysis, and 28 of 30 agreed to undergo an ultrasound rectal examination. Data obtained from the semen tests and from the ultrasound study were compared. RESULTS Cysts in the seminal tract were present in 10 (43.47%) of 28 individuals. Twenty of 22 patients showed abnormal semen parameters, with asthenozoospermia as the most common finding. No correlation between ultrasound findings and sperm abnormalities was observed. CONCLUSIONS The presence of cysts in the seminal tract is remarkably high (43.47%); however, this finding does not correlate with sperm abnormalities, which are also a frequent finding, especially asthenozoospermia. This semen abnormality is probably related to the abnormal function of polycystins. More attention should be paid to reproductive aspects in the initial evaluation of patients with autosomal dominant polycystic kidney disease before their ability to conceive is further impaired by uremia.
Nefrologia | 2012
Maitane del Pozo; J. Martí; Lluís Guirado; Carme Facundo; Cristina Canal; Pablo de la Torre; José Ballarín; J.M. Díaz
Transplant renal artery stenosis is a major complication that requires a therapeutic approach involving surgery or angioplasty. The aim of this study was to analyse the evolution of renal transplant patients with renal allograft artery stenosis treated by angioplasty and stent placement. Thirteen patients were diagnosed with transplant renal artery stenosis. Clinical suspicion was based on deterioration of renal function and/or poorly controlled hypertension with compatible Doppler ultrasound findings. The diagnosis was confirmed by arteriography, performing an angioplasty with stent placement during the same operation. A progressive improvement in renal function was observed during the first 3 months after the angioplasty, and renal function then remained stable over 2 years. In addition, blood pressure improved during the first 2 years, and as a consequence there was no need to increase the average number of anti-hypertensive drugs administered (2.5 drugs per patient). In conclusion, angioplasty with stent placement is a safe and effective procedure for the treatment of transplant renal artery stenosis.
Actas Urologicas Espanolas | 2012
C. Ochoa; Alberto Breda; J. Martí; P. de la Torre; Humberto Villavicencio
INTRODUCTION The incidence of renal artery stenosis in the transplanted kidney (TRAS) varies between 2 and 23%, being the most frequent vascular complication following renal trasplantation. The delay in diagnosis and treatment can lead to functional graft loss. Percutaneous trasluminal angioplasty with stent (PTAS) is the treatment of choice to restore kidney perfusion. MATERIALS AND METHODS Retrospective review of renal transplant casuistic in our institution between September 2005 and August 2009. Were included patients with greater than 70% TRAS and impaired graft function, treated with PTAS. Follow-up at 3, 12 and 36 months was done with creatinine, glomerular filtration rate (GFR) and Doppler ultrasonography (DUS). Technical success was defined as correct stent placement associated with decreased flow, and clinical success as improve renal function during follow-up. RESULTS Incidence of TRAS was 7.3% (22/298), 60% PTAS subsidiary. 100% technical success and 84.6% clinical success, 15.4% without changes in renal function. 84% decreases flow rate greater than 70% by DUS, and 26% up to 60%. Wave changes from type III to type II were recorded in 69% and to type I in 33%. CONCLUSIONS The PTAS is a safe and effective procedure for the treatment of selected TRAS patients, as it preserves vascular permeability in short and medium term, ensuring the functionality of the graft. DUS is the method of choice for diagnosis and monitoring TRAS.
Archivos españoles de urología | 2006
Anna Bujons; X. Pascual; J. Martí; P. De la Torre; H. Sarquella; Humberto Villavicencio
Resumen es: Objetivo: Se presenta el caso clinico de un paciente con priapismo de 4 anos de evolucion, su diagnostico y posterior manejo terapeutico. Metodos: Se rev...
Transplantation Proceedings | 2005
B. Juaneda; A. Alcaraz; Anna Bujons; Lluís Guirado; J.M. Díaz; J. Martí; P. de la Torre; S. Sabaté; Humberto Villavicencio
Transplantation Proceedings | 2005
A. Alcaraz; Anna Bujons; X. Pascual; B. Juaneda; J. Martí; P. de la Torre; Lluís Guirado; J.M. Díaz; M.J. Ribal; R. Solá; Humberto Villavicencio
Actas Urologicas Espanolas | 2015
O. Rodríguez-Faba; J. Palou; A. Rosales; P. de la Torre; J. Martí; A. Palazzetti; Humberto Villavicencio
Actas Urologicas Espanolas | 2015
O. Rodríguez-Faba; J. Palou; A. Rosales; P. de la Torre; J. Martí; A. Palazzetti; Humberto Villavicencio
Actas Urologicas Espanolas | 2012
C. Ochoa; Alberto Breda; J. Martí; P. de la Torre; Humberto Villavicencio
The Journal of Urology | 2013
J. Palou; Marco Cosentino; Giuseppe Lucarelli; Oscar Rodriguez Faba; J.M. Gaya; Pablo Torre; J. Martí; Alberto Breda; Lluís Gausa; Humberto Villavicencio